Evaluation of MicroScan Synergies plus Positive Combo 3 Panels for Identification and Antimicrobial Susceptibility Testing of Staphylococcus aureus and Enterococcus Species
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : Few studies have evaluated the performance of the recently introduced MicroScan Synergies plus Positive Combo 3 Panels (SIPC3) (Dade Behring Inc., USA). We evaluated the clinical efficacy of the panels in identification (ID) and antimicrobial susceptibility testing (AST) of Staphylococcus aureus and enterococci. Methods : To evaluate the panels’ accuracy of identification, the results obtained using the test panels were compared with those obtained by using conventional biochemical tests in conjunction with VITEK 2 system (bio-Merieux, USA). In addition, the AST results obtained using the panels were compared with those obtained by performing CLSI broth microdilution. Results : The overall agreement between the approaches for the ID of S. aureus and enterococci was 100% and 96%, respectively. The categorical and essential agreements (CA and EA) for S. aureus were 98%, each. Very major errors (VME), major errors (ME), and minor error (mE) for S. aureus were 0.45%, 0.3%, and 4.2%, respectively. The majority of VMEs were for oxacillin (8.6%), penicillin (2.0%), erythromycin (7.9%), clindamycin (3.8%), and tetracycline (4.1%). For enterococci, the CA, EA, VME,ME, and mE were 88.8%, 93.7%, 4.4%, 0%, and 2.8%, respectively. The 80.5% (29/36) of Enterococcus faecium had concordant ID with the reference. Most of the categorical errors (3 VMEs and 14 mEs) were observed for quinupristin/dalfopristin (Synercid; Catalytica Pharmaceuticals Inc., USA). Conclusions : The panels compared favorably with conventional methods for the ID and AST of S. aureus. However, we expected a better performance for ID of E. faecium and AST using Synercid. (Korean J Lab Med 2010;30:373-80)
Abstract
Background : Few studies have evaluated the performance of the recently introduced MicroScan Synergies plus Positive Combo 3 Panels (SIPC3) (Dade Behring Inc., USA). We evaluated the clinical efficacy of the panels in identification (ID) and antimicrobial susceptibility testing (AST) of Staphylococcus aureus and enterococci. Methods : To evaluate the panels’ accuracy of identification, the results obtained using the test panels were compared with those obtained by using conventional biochemical tests in conjunction with VITEK 2 system (bio-Merieux, USA). In addition, the AST results obtained using the panels were compared with those obtained by performing CLSI broth microdilution. Results : The overall agreement between the approaches for the ID of S. aureus and enterococci was 100% and 96%, respectively. The categorical and essential agreements (CA and EA) for S. aureus were 98%, each. Very major errors (VME), major errors (ME), and minor error (mE) for S. aureus were 0.45%, 0.3%, and 4.2%, respectively. The majority of VMEs were for oxacillin (8.6%), penicillin (2.0%), erythromycin (7.9%), clindamycin (3.8%), and tetracycline (4.1%). For enterococci, the CA, EA, VME,ME, and mE were 88.8%, 93.7%, 4.4%, 0%, and 2.8%, respectively. The 80.5% (29/36) of Enterococcus faecium had concordant ID with the reference. Most of the categorical errors (3 VMEs and 14 mEs) were observed for quinupristin/dalfopristin (Synercid; Catalytica Pharmaceuticals Inc., USA). Conclusions : The panels compared favorably with conventional methods for the ID and AST of S. aureus. However, we expected a better performance for ID of E. faecium and AST using Synercid. (Korean J Lab Med 2010;30:373-80)
참고문헌 (29)
- Lowy FD, "Staphylococcus aureus infections", N Engl J Med, 339, pp.520~532 (1998)
- Tenover FC, "Vancomycin-resistant staphylococci and enterococci: epidemiology and control", Curr Opin Infect Dis, 18, pp.300~305 (2005)
- 이경원, "Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea", Yonsei Medical Journal, 47(1), pp.43~54 (2006), 연세대학교의과대학
- 김경미, "2004 년도 전국 16개 대학병원 중환자실 병원감염 감시 결과", 병원감염관리, 11, pp.79~86 (2006)
- Ito T, "Acquisition of methicillin resistance and progression of multiantibiotic resistance in methicillin-resistant Staphylococcus aureus", Yonsei Med J, 39, pp.526~533 (1998)
- Livermore DM, "Antibiotic resistance in staphylococci", Int J Antimicrob Agents, 16(S1), pp.S3~S10 (2000)
- Swenson JM, "Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp", J Clin Microbiol, 43, pp.3818~3823 (2005)
- Swenson JM, "Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms", J Clin Microbiol, 39, pp.3785~3788 (2001)
- Sakoulas G, "Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains", J Clin Microbiol, 39, pp.3946~3951 (2001)
- Felten A, "Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test", J Clin Microbiol, 40, pp.2766~2771 (2002)
- Yamazumi T, "Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus", J Clin Microbiol, 39, pp.53~56 (2001)
- Ribeiro J, "Misclassification of susceptible strains of Staphylococcus aureus as methicillin-resistant S. aureus by a rapid automated susceptibility testing system", J Clin Microbiol, 37, pp.1619~1620 (1999)
- Eigner U, "Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems", J Clin Microbiol, 43, pp.3829~3834 (2005)
- 전경란, "Methicillin 내성 황색포도알균의 검출을 위한 Phoenix System의평가", 대한임상미생물학회지, 9(1), pp.58~63 (2006), 대한임상미생물학회
- 이위교, "Vancomycin 내성 장구균의 분리율, 항균제 감수성 및 내성형에 관한 연구", 대한임상병리학회지, 18, pp.51~56 (1998)
- 이위교, "Resistance Mechanism and Epidemiology of Vancomycin-resistant Enterococci", 대한임상미생물학회지, 11(2), pp.71~77 (2008), 대한임상미생물학회
- 어영, "그람양성과 그람음성세균에 대한 MicroScanⓇ Synergies plus Combo Panel과 MicroScanⓇ Conventional Combo Panel의 비교", 대한임상미생물학회지, 12(4), pp.193~200 (2009), 대한임상미생물학회
- Clinical and Laboratory Standards Institute, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically:approved standard. CLSI document M07-A7. 7th ed" (2006), CLSI
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial disk susceptibility tests: approved standard. CLSI document M02-A9. 9th ed" (2006), CLSI
- Schreckenberger P, "Multicenter evaluation of vancomycin on a Synergies Plus Pos Dired Panel with Staphylococci and Enterococci. American Society for Microbiology 2007:Abstract C-011", ~ (2007)
- Nothaft D, "Staphylococci and rapid identification: primary analysis of the new MicroScan Rapid Pos ID 2 Panel for two hour identification of clinically relevant Staphylococci. American Society for Microbiology 2006:Abstract C-014", ~ (2006)
- Kaase M, "Performance of MicroScan WalkAway and Vitek 2 for detection of oxacillin resistance in a set of methicillin-resistant Staphylococcus aureus isolates with diverse genetic backgrounds", J Clin Microbiol, 47, pp.2623~2625 (2009)
- Bobolis J, "Rapid identification of streptococci and enterococci: preliminary evaluation of new microorganisms with the new MicroScan Rapid Pos ID 2 Panel. American Society for Microbiology 2006:Abstract C-015", ~ (2006)
- 송원근, "MicroScan panel을 이용한 장구균 균종 동정의 평가", 임상병리와 정도관리, 19, pp.173~177 (1997)
- 정재우, "BACTEC 혈액배양병 양성검체에서 직접접종법에 의한 균종동정과 항균제감수성검사를 위한 MicroScan과 Phoenix 시스템의 평가", The Korean Journal of Laboratory Medicine, 29(1), pp.25~34 (2009), 대한진단검사의학회
- Iwen PC, "Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels", J Clin Microbiol, 34, pp.1779~1783 (1996)
- d’Azevedo PA, "Evaluation of an automated system for the identification and antimicrobial susceptibility testing of enterococci", Diagn Microbiol Infect Dis, 40, pp.157~161 (2001)
- Marco F, "Evaluation of the Phoenix system for identifying and determining the susceptibility of clinical isolates. Comparative study with the Microscan system", Rev Esp Quimioter, 17, pp.169~176 (2004)
- Kim YR, "Comparison of the MicroScan system and the agar dilution assay for quinupristin", dalfopristin susceptibility of Enterococcus facecium, 2007, pp.37, 260~262